NCT05321940 2023-12-04
Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias
University of Miami
Phase 1 Withdrawn
Clinical Trials
1 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all